The Biggest Biotech Companies

Biotechnology uses living organisms to develop cutting-edge medical treatments and drugs to treat diseases and ease human suffering. The biotech sciences include genetics, genetic engineering, gene therapy, applied immunology, and bioengineering. Companies that break ground in these areas may profit handsomely. Those that do not may fiscally suffer.

The difficulty in predicting which path such companies will take makes the biotech industry notoriously more volatile than the broader stock market. Consequently, investors willing to accept more risk, for the promise of excessively higher returns, may wish to diversify their equity portfolio with a stable of biotech stocks.

The Biggest Biotech Stocks

The largest biotech companies by market capitalization currently listed on U.S. stock exchanges as of Jan. 11, 2021, are:

Specialization / Focus
Market Capitalization ($Billions US)
Novo Nordisk

Hemophilia, diabetes, obesity
Vertex Pharmaceuticals
VRTX Cystic fibrosis 61.0
Regeneron Pharmaceuticals
Cancer, allergic and inflammatory diseases, cardiovascular and metabolic diseases
Moderna MRNA Infectious and rare diseases, cancer, cardiovascular disease 46.4
Alexion ALXN Severe and ultra-rare disorders 34.2
Royalty Pharma RPRX Biotechnology royalties 32.1
Genmab A/S GMAB Antibody products for cancer patients 
BioNTech BNTX Cancer immunotherapy 26.2
BGNE Cancer

Source: Yahoo! Finance

Biotech ETFs

Biotech stocks can rise or fall, based on a host of company-specific factors, such as research announcements and Food and Drug Administration (FDA) clinical trial results. Therefore investors may wish to diversify their biotech exposure by allocating portions of their portfolios to biotech mutual funds or biotech exchange-traded funds (ETFs) such as SPDR S&P Biotech ETF (XBI), iShares Biotechnology Index (IBB), Market Vectors Biotech ETF (BBH) and PowerShares Dynamic Biotech & Genome ETF (PBE).

The Bottom Line

Biotechnology is on the front line of medical research and technology. Investing in biotech companies can pay off handsomely, given the industry’s potential for high profits, but the high risks associated with these firms can produce substantial losses. An investor can mitigate that risk by investing in mutual funds or ETFs, in order to diversify their biotech holdings.

Take the Next Step to Invest
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.